Letter

Peripheral arterial disease: still on the periphery?

BMJ 2006; 332 doi: 10.1136/bmj.332.7551.1213 (Published 18 May 2006)
Cite this as: BMJ 2006;332:1213.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Belch Jill (J.J.F.Belch@Dundee.ac.uk), professor of vascular medicine,
  2. Gerry Stansby, professor of vascular surgery
  1. Vascular Diseases Research Unit, Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY,
  2. Northern Vascular Unit, Freeman Hospital, Newcastle upon Tyne NE7 7DN

    EDITOR—Changes to the UK General Medical Services (GMS) quality and outcomes framework review include several new therapeutic areas.1 However, although the GMS contract continues to emphasise risk factor management in patients with coronary heart disease, stroke, or transient ischaemic attack, it again omits peripheral arterial disease, even though this has largely the same underlying cause and association with cardiovascular events and mortality. This omission is even more noticeable given …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular